So if you look at GLP-1s and you talk about the failure rate of GLP-1s, youre talking that in 12 to 18 months, 50% to as much as 80% of the people are quote-unquote failing
Building on striking phase 2 data which showed mean body weight reductions of approximately 24% at the highest dose over 48 weeks retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, potentially offering a more powerful metabolic effect than existing treatments
Though its intended purpose is to moderate insulin levels in diabetics, new users are overwhelmingly adopting the drug for its notable weight loss side effects
The goal is to identify what changed and rebuild support before the regain becomes larger
And at Waverley Oaks, you dont have to go it alone
doi: 10.1185/03007991003672551 33 PratleyRENauckMBaileyTMontanyaECuddihyRFilettiSet al